Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

1.

Glucagon-like Peptide-1 as predictor of body mass index and dentate gyrus neurogenesis: neuroplasticity and the metabolic milieu.

Coplan JD, Syed S, Perera TD, Fulton SL, Banerji MA, Dwork AJ, Kral JG.

Neural Plast. 2014;2014:917981. doi: 10.1155/2014/917981. Epub 2014 Nov 23.

PMID:
25506432
[PubMed - in process]
Free PMC Article
3.

Efficacy and risk of hypoglycemia with use of insulin glargine or comparators in patients with cardiovascular risk factors.

Blonde L, Baron MA, Zhou R, Banerji MA.

Postgrad Med. 2014 May;126(3):172-89. doi: 10.3810/pgm.2014.05.2766.

PMID:
24918802
[PubMed - indexed for MEDLINE]
4.

Influence of baseline glycemia on outcomes with insulin glargine use in patients uncontrolled on oral agents.

Banerji MA, Baron MA, Gao L, Blonde L.

Postgrad Med. 2014 May;126(3):111-25. doi: 10.3810/pgm.2014.05.2761.

PMID:
24918797
[PubMed - indexed for MEDLINE]
5.

Pheochromocytoma: a review.

Tsirlin A, Oo Y, Sharma R, Kansara A, Gliwa A, Banerji MA.

Maturitas. 2014 Mar;77(3):229-38. doi: 10.1016/j.maturitas.2013.12.009. Epub 2014 Jan 5. Review.

PMID:
24472290
[PubMed - indexed for MEDLINE]
6.

Diabetes and bone health.

Antonopoulou M, Bahtiyar G, Banerji MA, Sacerdote AS.

Maturitas. 2013 Nov;76(3):253-9. doi: 10.1016/j.maturitas.2013.04.004. Epub 2013 Apr 28. Review.

PMID:
23628280
[PubMed - indexed for MEDLINE]
7.

Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial.

Bray GA, Smith SR, Banerji MA, Tripathy D, Clement SC, Buchanan TA, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Schwenke DC, Stentz FB, Reaven PD, DeFronzo RA.

Diabetes Obes Metab. 2013 Oct;15(10):931-7. doi: 10.1111/dom.12099. Epub 2013 May 7.

PMID:
23551856
[PubMed - indexed for MEDLINE]
8.

Hypopituitarism in the elderly.

Antonopoulou M, Sharma R, Farag A, Banerji MA, Karam JG.

Maturitas. 2012 Aug;72(4):277-85. doi: 10.1016/j.maturitas.2012.05.002. Epub 2012 Jun 20. Review.

PMID:
22727068
[PubMed - indexed for MEDLINE]
9.

Non-insulin injectable treatments (glucagon-like peptide-1 and its analogs) and cardiovascular disease.

Lebovitz HE, Banerji MA.

Diabetes Technol Ther. 2012 Jun;14 Suppl 1:S43-50. doi: 10.1089/dia.2012.0022.

PMID:
22650224
[PubMed - indexed for MEDLINE]
10.

Corticotropin releasing factor (CRF) and obesity.

Sharma R, Banerji MA.

Maturitas. 2012 May;72(1):1-3. doi: 10.1016/j.maturitas.2012.01.015. Epub 2012 Feb 27. No abstract available.

PMID:
22377185
[PubMed - indexed for MEDLINE]
11.

Chronic kidney disease and diabetes.

Pyram R, Kansara A, Banerji MA, Loney-Hutchinson L.

Maturitas. 2012 Feb;71(2):94-103. doi: 10.1016/j.maturitas.2011.11.009. Epub 2011 Dec 3. Review.

PMID:
22137331
[PubMed - indexed for MEDLINE]
12.

Utilizing current diagnostic criteria and treatment algorithms for managing type 2 diabetes mellitus.

Kruger DF, Boucher JL, Banerji MA.

Postgrad Med. 2011 Jul;123(4):54-62. doi: 10.3810/pgm.2011.07.2304. Review.

PMID:
21680989
[PubMed - indexed for MEDLINE]
13.

Chronobiology impacts response to antihypertensive drug regimen in type 2 diabetes.

Friedman EA, Banerji MA.

Diabetes Care. 2011 Jun;34(6):1438-9. doi: 10.2337/dc11-0576. No abstract available.

PMID:
21617113
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Metabolic syndrome and neurometabolic asymmetry of hippocampus in adult bonnet monkeys.

Coplan JD, Abdallah CG, Mathew SJ, Shungu DC, Mao X, Smith EL, Kaufman D, Gorman JM, Owens MJ, Nemeroff CB, Banerji MA, Rosenblum LA, Kral JG.

Physiol Behav. 2011 Jul 6;103(5):535-9. doi: 10.1016/j.physbeh.2011.03.020. Epub 2011 Apr 1.

PMID:
21459102
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: a retrospective analysis of the GALIANT study.

Banerji MA, Purkayastha D, Francis BH.

Diabetes Res Clin Pract. 2010 Nov;90(2):182-90. doi: 10.1016/j.diabres.2010.06.022. Epub 2010 Jul 23.

PMID:
20655609
[PubMed - indexed for MEDLINE]
16.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I; ACCORD trial group.

Lancet. 2010 Aug 7;376(9739):419-30. doi: 10.1016/S0140-6736(10)60576-4. Epub 2010 Jun 30. Erratum in: Lancet. 2010 Oct 30;376(9751):1466.

PMID:
20594588
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Calles-Escandón J, Lovato LC, Simons-Morton DG, Kendall DM, Pop-Busui R, Cohen RM, Bonds DE, Fonseca VA, Ismail-Beigi F, Banerji MA, Failor A, Hamilton B.

Diabetes Care. 2010 Apr;33(4):721-7. doi: 10.2337/dc09-1471. Epub 2010 Jan 26.

PMID:
20103550
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study.

DeFronzo RA, Banerji MA, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner R, Reaven P, Schwenke DC, Stentz FD, Tripathy D; ACT NOW Study Group.

Diabetologia. 2010 Mar;53(3):435-45. doi: 10.1007/s00125-009-1614-2. Epub 2009 Dec 10.

PMID:
20012012
[PubMed - indexed for MEDLINE]
19.

Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial--a primary care, type 2 diabetes study.

Blonde L, Dagogo-Jack S, Banerji MA, Pratley RE, Marcellari A, Braceras R, Purkayastha D, Baron M.

Diabetes Obes Metab. 2009 Oct;11(10):978-86. doi: 10.1111/j.1463-1326.2009.01080.x. Epub 2009 Jul 13.

PMID:
19614942
[PubMed - indexed for MEDLINE]
20.

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea.

Garber AJ, Foley JE, Banerji MA, Ebeling P, Gudbjörnsdottir S, Camisasca RP, Couturier A, Baron MA.

Diabetes Obes Metab. 2008 Nov;10(11):1047-56. doi: 10.1111/j.1463-1326.2008.00859.x. Epub 2008 Feb 18.

PMID:
18284434
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk